Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS ) 35.13 -0.46 (-1.28%) Streaming Delayed Price Updated: 10:56 AM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GeneDx Holdings Corp. - Class A Common Stock < Previous 1 2 3 4 5 Next > Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 18, 2024 Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates. Via Benzinga GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics March 14, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Earnings Preview: GeneDx Hldgs February 19, 2024 Via Benzinga GeneDx Hldgs's Earnings: A Preview October 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session March 08, 2024 Via Benzinga GeneDx to Participate in 44th Annual Cowen Health Care Conference February 26, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session February 22, 2024 Via Benzinga GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 February 20, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Earnings Scheduled For February 20, 2024 February 20, 2024 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. Via Benzinga GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 February 01, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session January 25, 2024 Via Benzinga GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 24, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session January 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 10, 2024 Via Benzinga GeneDx Announces Preliminary 2023 Financial Results January 08, 2024 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy December 01, 2023 New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior clinical results compared to multi-gene... From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference November 28, 2023 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session November 24, 2023 Via Benzinga GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 20, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2 November 09, 2023 The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 31, 2023 Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... Via Benzinga Topics Intellectual Property Exposures Intellectual Property 12 Health Care Stocks Moving In Monday's After-Market Session October 30, 2023 Via Benzinga GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights October 30, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023 October 09, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday September 28, 2023 During Thursday's session, 406 companies made new 52-week lows. Via Benzinga Earnings Scheduled For October 30, 2023 October 30, 2023 Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. Via Benzinga GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 22, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga GeneDx Announces Evolution of Executive Leadership Team September 11, 2023 Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership... From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced September 06, 2023 From GeneDx Holdings Corp. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.